Kovack Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Kovack Advisors's ELV Position: Q2 2026 in Review
Kovack Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 602 shares worth $249K. The stake represents 0.01% of the portfolio and ranks #896 among its holdings. This is a return to the name: Kovack Advisors previously reported a position in ELV as recently as Q4 2025.
Kovack Advisors first reported a position in ELV in Q4 2018 and has held it in 22 quarters since. The position peaked at $477K in Q4 2021. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Kovack Advisors held 602 shares of Elevance Health worth $249K as of Q2 2026.
- Elevance Health was a new Kovack Advisors position in Q2 2026.
- Elevance Health made up 0.01% of Kovack Advisors's portfolio in Q2 2026, its #896 holding.
- Kovack Advisors first reported a position in Elevance Health in Q4 2018 and has held it in 22 quarters since.
- Kovack Advisors's Elevance Health position peaked at $477K in Q4 2021.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.